Elongation factor-1 alpha (EFla) is a ubiquitous, highly conserved protein that functions in peptide elongation during mRNA translation. We recently reported that, as do lower species, mammals also contain a second EF-la-like gene (Sl).
Introduction
It is becoming increasingly evident that protein translation plays an important role in the control of gene expression (for review see 8) . One of the key components of the protein translational apparatus is elongation factor-1 alpha (EFla), a 50 KD protein that promotes GTP-dependent binding ofaminoacyl tRNA to the ribosomal complex during peptide elongation. It is a very highly conserved protein, present in high abundance in cells of all organisms that have been studied thus far (4,7,9,10,12,13,20,22,23) .
The genomes of different eucaryotic species have been shown to contain several active EF-la genes (3, 9, 24) . In Drosophila (9) and Xenopus ( 5 ) , the expression of the different EFla genes is developmentally regulated; although all genes are active during development, only one EF-la is expressed in adult tissues. Thus far, no function for the extra EF-la protein has been discovered, but it has been suggested that the overexpression of a stage-specific form of EF-la may result in increased translational accuracy, as observed in yeast (18) . Supported We demonstrate that although EFla mRNA can be detected in SI-negative cells it is also present in high abundance in SI-positive cells. The results presented here correlate with our previous fmding that IIliltntnaliatl speciescontainatissuespecific EF-la-like gene, SI. The presence of a second EFla-like transcript within fully differentiated cells suggests a novel cell type-specific gene expression whose funaion may be related to the permanent growth-arrested state of cells in brain, heart, and muscle. (J Histochem Cytochem Mammalian species also contain a second EF-la-like gene. We recently reported the cloning of a 1.7 KB cDNA, S1, that shares high sequence similarity with the known human EF-la (>92% amino acid) (1, 2) . We showed by Northem analysis and RNAse protection assay that the S1 gene is expressed in adults but only in three well-defined tissues, brain, heart and muscle, whereas we detected EF-la transcript in all tissues (11) . To verify the tissue specificity of S1 gene expression, we show in this report the cellular distribution of S1 and EFla mRNA in brain and liver by in situ hybridization. We also present a method to ver@ the production of full-length, digoxigenin-labeled cRNA, and its application in localizing messenger RNA. The data presented here define SI expression in cells that are probably locked permanently in the nongrowing state, such as those of brain and muscle tissues, whereas EF-la mRNA can be detected in all cells.
Materials and Methods

Matenah
[32P]-UTP (650 Ci/mmol) was purchased from ICN Biochemicals Canada (Montreal, PQ, Canada); the pGEM plasmid and Riboprobe synthesis sptem was from Promega (Madison, WI); digoxigenin-ll-UTP and detection system was from Boehringer Mannheim Canada (Lad, PQ, Canada); all restriction enzymes were purchased from Pharmacia (Piscataway, NJ), ex-1093 Figure 1 . Digoxigenin-UTP labeling of S1-and EF-laspecific cRNAs. (A) In vitro transcription of plasmid pS1-7 was performed a s described in Materials and Methods in the presence o f (Lane 1) 0 pM digoxygenin-11-UTP, 500 pM unlabeled UTP: (Lane 2) 250 pM digoxygenin-11-UTI? 250 pM unlabeled UTP; and (Lane 3) 500 pM digoxygenin-1 1-UTP, 0 pM unlabeled UTP. In each case, a small amount of [3zP]-UTP (<0.1 pCi) was added to the reaction mixture. (E) Synthesis of full-length S1 (Lane 1) and EF-la cRNAs (Lane 2). After incubation, an aliquot of each reaction mixture was run on a 6% urealpolyacrylamide gel. The gel was autoradiographed for 2 hr at -9OOC. Methods S1 and Rat EF-la cRNA Probe Synthesis. The construction of thr S1 (pS1-7) and EF-la (pEF-la-1) plasmid and synthesis of the 3' non-coding region cRNA were carried out as described (11) . Minor modificqtions were added for the synthesis of dioxygenin-1 I-UP-labeled cRNA (19) . Briefly, linearized plasmid (1 pglml) was incubated for 1 hr at 37'C in a solution containing transcription buffer, 20 U of RNAsin (RNAse inhibitor), 10 pM dithiothreitol (DTT). GTP, ATP, CTP (500 pM each), unlabeled and dioxygenin-labeled UTP (250 pM each), and 40 U of T7 (anti-sense) or SP6 (sense) RNA polymerase. After the initial incubation, an additional 20 U of polymerase was added to the reaction mixture. The reaction was terminated by exhaustive DNAse I digestion followed by ethanol precipitation. and the reaction mixture was re-suspended in diethylpyrocarbonare (DEPC)-treated water. To verify that high-quality, digoxigenin-labeled fulllength transcripts were synthesized with our methods, trace amounts of [3*P]-UTP (<1 pCi) were added to the reaction mixture. The transcription product was treated as described above and was analyzed by 6% polyacryl-amide17 M urea gel electrophoresis. Exposure time of the gel to the autoradiograph was 2 hr.
Tissue Preparation for In Situ Hybridization. The method used is essentially as described (19) . Male Fischer 344 rats were decapitated and the brain and liver quickly removed and frozen on dry ice. Sections were cut at a thickness of 10 pm on a cryostat. thaw-mounted on poly-L-lysine-coated slides, and stored at -9O'C for less than 2 days. On the day of the experiment, sections were fixed for 5 min in 3% paraformaldehyde made up fresh in 0.1 M PBS and washed briefly rwice in PBS.
Pre-hybridization. After fixation, sections were briefly washed in 2 x SSC (saline sodium citrate), acetylated for 10 min in 0.25% acetic anhydride, 0.1 M triethanolamine (pH 8.0). rinsed in 2 x SSC. in PBS, and 30 min in 0.1 M Trislglycine buffer (pH 7.0). The sections were briefly washed in 2 x SSC, dehydrated in ethanol. and allowed to air-dry.
Hybridization. Each section was covered with 100 pI of hybridization buffer containing 40% deionized formamide. 10% dextran sulfate, 1 x Denhardt's solution (0.02% Ficoll. polyvinyl pyrolidone. and bovine serum albumin each), 4 x SSC. 10 mM MT, 1 mglml yeast total RNA, and digoxigenin-11-UTP-labeled EF-la or SI cRNA. Hybridization was conducted at 45°C for 4 hr. After hybridization the slides were washed in 50% formamide containing 2 x SSC at 5O' C, treated with RNAse A (20 pglml) in 2 x SSC at 37'C for 30 min. rinsed in 2 x SSC at room temperature. and incubated for 15 min in 50% formamide. 2 x SSC. The slides were left overnight in 2 x SSC containing 0.05% Triton X-100 and 2% fetal calf serum at room temperature. For detection of signal, the sections were treated as described in the manufacrurer's protocol (Boehringer Mannheim), but with a final dilution of the anti-digoxigenin-alkaline phosphataseconjugated antibody at 1:2000.
Results
We previously demonstrated that S1 shares high amino acidsequence similarity with the known elongation factor EF-la & ? ) . In our previous report, we demonstrated by RNAse protection and Northern analysis the tissue-specific expression of S1 in brain, heart, and muscle (11) . With these two techniques we could not detect any signal in the other tissues that we examined. To further verify the tissue specificity in expressing either or both S1 and EF-la genes, we performed in situ hybridization on brain and liver sections.
The probes that we used for in situ hybridization were the same as previously described (11) . These probes are targeted to the 3' non-coding regions of S1 and EF-la mRNA, which differ considerably in their sequence. The demonstration of probe specificity to cept for BstNI from Stratagene (La Jolla. CA); rats were from either Harlan Sprague-Dawley (Indianapolis, IN) or were Fischer 344 from the aging rat colony of the National Institute on Aging ofthe National Innitutes of Health (Bethesda. MD).
. . increase in the size of the transcript, as shown in Figure 1A . The presence of high amounts of digoxigenin-11-UTP andlor the absence of unlabeled UTP did not cause any major problem in transcript synthesis (e.g., polymerase pausing, wrong strand synthesis). Probe quality was also analyzed by the direct detection method, b Figure 2 . Cellular localization of S1 and EF-la mRNA in rat liver. Photomicrograph of liver section hybridized with DIG-labeled (A) S1 anti-sense cRNA, (6) EF-la anti-sense cRNA. and (C) EF-la sense probe control. Arrows point at nuclei. Note that the dense signal for EF-la anti-sense probe is confined to cytoplasmic regions of the cells. Bars = 25 fim.
their respective genes has been previously described in detail (11) . In addition, because success of in situ hybridization is partially due to probe quality, we verified probe synthesis by adding trace amounts of [ 32P]-uTP to the reaction mixture and performed polyacrylamide gel electrophor& to analyze both newly synthesized cRNAs. Figure shows that digoxigenin-ll-u~ can be incorporated into full-length transcripts with the described method; incorporation of digoxigenin-labeled UTP in the transcription product led to an as suggested by the manufacturer (Boehringer Mannheim; data not shown). The combination of both methods ensured that the cRNAs used in these experiments were full-length transcripts labeled to high specific activity. Figure 2 shows representative results from in situ hybridization on liver sections. We did not detect any signal over background in any fields of liver hybridized to dioxygenin-labeled S1 cRNA ( Figure 2A) ; in contrast, we detected very intense staining in the cytoplasm of all the cells when sections were hybridized with the EF-la probe ( Figure 2B ). The fact that the signal was mostly confined to the cytoplasm indicates specificity of hybridization. Sense control did give some nonspecific signal in certain cells, but the level of staining intensity was significantly lower than that observed for the EF-la anti-sense probe ( Figure 2C ). These results are in agreement with our previously published report (11) indicating the absence of signal for S1 and the 'presence of high-abundance transcript for EF-la in liver.
In situ hybridization was also performed on different regions of rat brain. First, we detected a very strong signal in hippocampus and cortex when sections were hybridized to either S1 (Figure 3) or EF-la (Figure 4) . compared with sense control. Staining was observed in the hippocampus, specifically the dentate gyrus region and cortex, and was restricted to the cytoplasm of these cells (Figure 4B) . In fact, in this region of the brain most cells were positive for both mRNAs. Areas of sections that were not stained corresponded to the molecular layer, mainly long axon extension and little content of cell bodies (where mRNA might be found). The co-localization of both transcripts suggests that the expressions of S1 and EF-la are not mutually exclusive (i.e., EF-la mRNA is present in S1-positive cells). Results obtained from the brain are also in agreement with our previous report indicating the presence of high amounts of both transcripts (11) .
The situation is more complex in the cerebellum and medulla (Figure 5 ) ; there, only a subset of cells is positive for S1 mRNA. In the cerebellum, the staining pattern suggests that S1 expression is limited to Purkinje cell bodies that border the granular and molecular layers; the signal observed was always less intense than in the hippocampus region. We could also detect some strongly stained cells, resembling pyramidal cells, in the medulla. Here, only a small fraction of the cells stained for S1, indicating that not all brain cells are S1 positive. In all cases, EF-la mRNA was detected in both cerebellum and medulla (data not shown).
Discussion
We report here the cellular distribution of S1 and EF-la mRNA by in situ hybridization. We show that the non-radioactive digoxigenin system can be used to distinguish between two very similar mRNAs. In general, owing to the result of bad probe synthesis or very low incorporation of digoxigenin-11-UTP, the described DIG procedure does not always produce satisfactory results. Using this method with the addition of trace amounts of label, we verify that the probes used are full-length and labeled to high specific activity. By verifying probe quality, we can perform in situ hybridization with high reproducibility.
The results obtained by in situ hybridization are in agreement with our previous report describing S1 expression as limited to three tissues in mammals: brain, heart, and muscle (11) . We could not detect S1 mRNA in any liver cells, showing that the absence of signal by Northern analysis and RNAse protection is valid and is not due to possible heterogeneous distribution of S1 in that tissue. liken together, these results strongly confirm that the S1 gene is indeed not expressed at all in liver; in contrast, our results show that all hepatocytes are positive for EF-la mRNA. The presence of EF-la in all cells confirms other reports indicating the highly ubiquitous nature of the protein (4.7.9-13.20.22.23).
In situ hybridization was also performed in two different regions of the brain. In the cerebellum and medulla, only some cells are S1 positive. This observation is in contrast with that in the hippocampus, where most cells are S1 positive. We feel that it is too early to confirm the exact nature of the cellular distribution of S1 in brain, but it appears that Purkinje cells and some other neurons are positive. We are presently addressing this question by immunohistochemical studies using neuronor glial-specific antibodies and confocal microscopy technology. The presence of S1 mRNA in brain, however, as detected by in situ hybridization, also confirms our previous finding that S1 mRNA is present in high abundance in this tissue.
The similar staining patterns we observed for S1 and EF-la mRNA in the hippocampus and cortex strongly suggest that in certain cases EF-la and S1 expressions overlap. This observation was confirmed in the muscle cell-culture system, where we detected EF-la mRNA in myoblasts and myotubes. whereas S1 mRNA was only observed in the myotubes (data not shown). It is interesting that cells in the brain that already express very high amounts of EF-la transcript also express S1 mRNA. The presence of S1 where there is abundant EF-la suggests a possible novel way of regulating an aspect of the elongation stage of protein synthesis. Hence, an increase in the cellular pool of active EF-la could result in enhanced translation fidelity as shown in yeast (18) and also in decreased translation efficiency and growth rate, as reported experimentally (14.17,21) and as predicted by computer simulation (16) of protein translation mechanisms. However, there are several instances in which unrelated genes such as actin-binding protein (25) . spindleassociated protein (IS), and RNP (6) show high homology to the EF-la sequence. Because of these observations, we remain open to the possibility that S1 possesses some function other than the tradi-tional function of EFla; rather, it may prove to be associated with some aspects of control mechanisms that determine the program of terminal differentiation in muscle and brain.
